Join
Live feed
·
PRReleasevia Quantisnow
Exicure Inc. logo

Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant

ByQuantisnow·Wall Street's wire, on your screen.
XCUR· Exicure Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track XCUR (Exicure Inc.) and more on Quantisnow.